Combining GLP-1 and glucagon for the treatment of obesity and diabetes

被引：0
|
作者：
Idris, Iskandar [1 ]
机构：
[1] Univ Nottingham, Nottingham NG7 2RD, England
来源：
DIABETES OBESITY & METABOLISM | 2013年 / 15卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：481 / 482
页数：2
相关论文
共 50 条
  • [1] Discovery of Insulin/GLP-1/Glucagon Triagonists for the Treatment of Diabetes and Obesity
    Huang, Chunhui
    Palani, Anandan
    Yang, Zhiqiang
    Deng, Qiaolin
    Reddy, Vijay
    Nargund, Ravi P.
    Lin, Songnian
    Altezza, Simona
    Bianchi, Elisabetta
    Orvieto, Federica
    Carrington, Paul
    [J]. ACS MEDICINAL CHEMISTRY LETTERS, 2022, : 1255 - 1261
  • [2] Glucagon-like peptide 1 (GLP-1) in the treatment of diabetes
    Nauck, MA
    [J]. HORMONE AND METABOLIC RESEARCH, 2004, 36 (11-12) : 852 - 858
  • [3] Obesity - an indication for GLP-1 treatment? Obesity pathophysiology and GLP-1 treatment potential
    Torekov, S. S.
    Madsbad, S.
    Holst, J. J.
    [J]. OBESITY REVIEWS, 2011, 12 (08) : 593 - 601
  • [4] GLP-1/glucagon receptor co-agonism for treatment of obesity
    Miguel A. Sánchez-Garrido
    Sara J. Brandt
    Christoffer Clemmensen
    Timo D. Müller
    Richard D. DiMarchi
    Matthias H. Tschöp
    [J]. Diabetologia, 2017, 60 : 1851 - 1861
  • [5] GLP-1/glucagon receptor co-agonism for treatment of obesity
    Sanchez-Garrido, Miguel A.
    Brandt, Sara J.
    Clemmensen, Christoffer
    Mueller, Timo D.
    DiMarchi, Richard D.
    Tschoep, Matthias H.
    [J]. DIABETOLOGIA, 2017, 60 (10) : 1851 - 1861
  • [6] Physiology and pathophysiology of glucagon-like peptide-1 (GLP-1): The role of GLP-1 in the pathogenesis of diabetes mellitus, obesity, and stress
    Bojanowska, E
    [J]. MEDICAL SCIENCE MONITOR, 2005, 11 (08): : RA271 - RA278
  • [7] GLP-1 ANALOGS FOR THE TREATMENT OF OBESITY
    Sever, M. Jensterle
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A6 - A6
  • [8] GLP-1 and Amylin in the Treatment of Obesity
    T. Jorsal
    J. Rungby
    F. K. Knop
    T. Vilsbøll
    [J]. Current Diabetes Reports, 2016, 16
  • [9] GLP-1 and Amylin in the Treatment of Obesity
    Jorsal, T.
    Rungby, J.
    Knop, F. K.
    Vilsboll, T.
    [J]. CURRENT DIABETES REPORTS, 2016, 16 (01) : 1 - 7
  • [10] Striking the Balance: GLP-1/Glucagon Co-Agonism as a Treatment Strategy for Obesity
    Hope, David C. D.
    Vincent, Matthew L.
    Tan, Tricia M. M.
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2021, 12
12345